Clinical trial Recruiting at 1 site Interventional Ages 1 Year to 5

Assessing milk ladders for children with cow's milk protein allergy

Official title: Effectiveness and Safety of the 4-Step Versus 6-Step Milk Ladder in Children with IgE-Mediated Cow's Milk Protein Allergy: Protocol for an Open-Label Randomised Controlled Trial

Run by Medical University of Warsaw · NCT06664918 · Data updated 2026-11-12

This study is testing two different milk ladder plans to see which one helps young children with a cow's milk allergy tolerate milk better.

More Food Allergy trials

Quick facts

Study typeInterventional
Ages1 Year to 5 Years
SexAll
Enrollment92 (estimated)
SponsorMedical University of Warsaw
Academic / other
Drugs / interventionsimmunotherapy
Locations2 sites (Warsaw and 1 other locations)
StatusRecruiting
StartedDecember 3, 2024
Main results expectedDecember 2028
Study endsMarch 2029
Registry record updatedMarch 18, 2025
Trial IDNCT06664918 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are children aged 1 to 5 years with a confirmed diagnosis of IgE-mediated CMPA who have been on a therapeutic elimination diet.

Probably not a fit

Patients with uncontrolled asthma or other significant chronic diseases may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effectiveness and safety of two different milk ladder protocols, a 4-step and a 6-step, for children aged 1 to 5 years with IgE-mediated cow's milk protein allergy (CMPA). The trial is an open-label, randomized superiority design involving 92 children who will be assigned to one of the two protocols. Each child will undergo oral food challenges to assess their tolerance to non-heated cow's milk proteins after following the respective milk ladder protocol. The primary outcome is the percentage of children achieving tolerance by the end of the observation period.

Why it matters

Potential benefit: If successful, this study could provide a standardized approach to help children with CMPA develop tolerance to cow's milk, improving their quality of life.

How similar studies have gone: While there is limited scientific evidence regarding the effectiveness of milk ladders, this approach is being tested in a structured manner, making it a novel investigation.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age between 1 and 5 years.
* Diagnosis of IgE-mediated CMPA confirmed according to ESPGHAN guidelines, by a positive OFC with CMPs. In high-risk children (i.e., with a history of anaphylaxis), diagnosis based on positive skin prick testing and/or elevated specific IgE to CMPs is sufficient.
* On a therapeutic elimination diet for at least 6 months or up to 12 months of age.12
* Eligible regardless of the risk of systemic reaction (anaphylaxis) and asthma.
* Good overall health status.
* Parents without language barriers.
* Written informed consent signed by parents.
* Good cooperation with the child's guardians.

Exclusion Criteria:

* Uncontrolled asthma, defined as the presence of shortness of breath, chest tightness, cough, and/or auscultatory changes despite treatment.
* Signs of exacerbation of a chronic disease.
* Signs of acute infectious disease (i.e., acute runny nose, cough, subfebrile fever, or fever).
* Signs of exacerbation of another allergic disease (i.e., conjunctivitis, allergic rhinitis, atopic dermatitis).
* Anaphylaxis due to CMPs in the last 6 months.
* Used antihistamines within 3-10 days before the challenge (depending on the characteristics of the drug and the reason for use).
* Acquired tolerance to baked CMPs or higher steps of the milk ladder.
* Use of immunosuppressive drugs or immunotherapy

Where it's running

  • Medical University od Warsaw, Department od Pediatrics
    Warsaw, Poland
    Recruiting
  • Medical University od Warsaw
    Warsaw, Poland
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.